What is pulmonary embolism?Pulmonary embolism is the sudden blockage of an artery
in the lung. Once the artery is blocked, usually by one or more blood clots,
oxygen levels in the blood drop, and blood pressure in the lungs rises. Pulmonary embolism caused by large clots can cause sudden death,
usually within 30 minutes of when symptoms begin.1
Smaller clots may cause permanent damage to the heart and lungs. What causes pulmonary embolism?The most common cause of pulmonary embolism is a blood clot that
forms in a
deep vein in your leg, breaks loose, travels to the
lungs, and becomes trapped in one of the smaller lung arteries. Other
substances, such as tumors, air bubbles,
amniotic fluid, or fat that is released into the blood
vessels, may also block an artery, but such causes are rare. What are the symptoms? Shortness of breath is the most common symptom of pulmonary
embolism. You may have sharp chest pain, which can spread to your shoulder,
neck, jaw, or arm. You may also have a cough that produces a pink, foamy mucus.
Other symptoms may include anxiety, sweating, lightheadedness, fainting, rapid
heart rate or
palpitations, and an impending sense of doom. Symptoms
of pulmonary embolism often begin suddenly. What increases your risk of pulmonary embolism?A blood clot in the deep leg veins (deep vein thrombosis) is the
greatest risk factor for pulmonary embolism. Inactivity, especially long
periods of bed rest, long flights, or car trips, increases your risk of
pulmonary embolism because of reduced blood circulation. Recent surgery,
stroke, heart attack,
heart failure, cancer, lung disease, being overweight,
using birth control pills, and smoking are also risk factors for pulmonary
embolism. Some people have blood that clots too quickly, and they are more
likely to develop clots that cause deep vein thrombosis or pulmonary embolism.
Conditions that cause increased clotting include inherited factors, cancer, and
severe infections. Injury to a blood vessel also increases the risk of deep
vein thrombosis. How is pulmonary embolism diagnosed?Many different types of tests, such as a chest X-ray, spiral CT
scan, lung scan, or ultrasound, can be used to diagnose pulmonary embolism.
However, it can be difficult to diagnose because other conditions, such as a
heart attack, panic attack, or pneumonia, can cause similar symptoms. Your doctor will consider your symptoms and risk factors for
pulmonary embolism before deciding which tests you should have first. If you
are at risk for pulmonary embolism and have symptoms, you should seek emergency
care immediately. Some people with this condition, however, have no
symptoms. How is it treated?Treatment focuses on preventing another clot from developing and
preventing existing clots from growing. Heparin and warfarin are anticoagulant
medications that are most commonly given to prevent the growth of existing
blood clots or the development of new blood clots. Blood clots that cause
pulmonary embolism often will dissolve on their own in a few weeks or months,
although they may never dissolve completely. In rare cases, other treatments for pulmonary embolism may be
considered. Clot-dissolving drugs (thrombolytics) may be used, or a surgeon may
remove the clot in a procedure called an embolectomy. To prevent future
pulmonary embolism, a filter may be placed inside the large central vein (vena
cava) of the body to trap clots and prevent them from traveling to the
lungs. See an illustration of a
clot that may lead to pulmonary embolism. Frequently Asked Questions |
Learning about pulmonary
embolism: |
| |
Being diagnosed: |
| |
Getting treatment: |
|
Pulmonary embolism is caused by a blocked artery in
the lungs. The most common cause of such a blockage is a blood clot that forms
in a
deep vein in the leg and travels to the lungs, where
it becomes lodged in a smaller lung artery. Over 95% of blood clots that cause pulmonary embolism are formed in
the upper
deep
leg veins.2 Clots can also form in the lower
deep veins of the legs as well as the deep veins of the arms or pelvis.
However, only about 20% of blood clots in the veins of the calf will become
larger and move into the upper leg or groin veins.3 Occasionally blood clots develop in
surface veins, but these clots rarely lead to
pulmonary embolism. In rare cases, pulmonary embolism may be caused by other
substances, including:4 - Tumors caused by rapidly growing cancer
cells.
- Air bubbles from trauma, surgery, or medical
procedures.
- Amniotic fluid from normal or complicated pregnancy and
childbirth (very rare).
- Small masses of infectious
material.
- Fat, which can be released into the bloodstream after
some types of bone fractures, surgery, trauma, or severe burns or from
diseases.
- Foreign substances, such as a catheter needle that can
break off during a medical procedure, mercury, iodine, cotton, or the growth of
tapeworm larvae.
The symptoms of
pulmonary embolism may include: - Shortness of breath that may occur
suddenly.
- Sudden, sharp chest pain that may become worse with deep
breathing or coughing.
- Rapid heart rate.
- Rapid
breathing.
- Sweating.
- Anxiety.
- Coughing up
blood.
- Fainting.
- Heart palpitations.
- Signs
of
shock.
Pulmonary embolism may be difficult to diagnose because its
symptoms may occur with or are similar to other conditions, such as a heart
attack, a panic attack, or pneumonia. Also, some people with pulmonary embolism
do not have symptoms. See a list of
other
conditions with similar symptoms.
If a large blood clot blocks the artery in the lung, blood flow may
be completely stopped, causing sudden death. A smaller clot reduces the blood
flow and may cause damage to lung tissue. However, if the clot dissolves on its
own, it may not cause any major problems. Symptoms of
pulmonary embolism usually begin suddenly. Reduced
blood flow to one or both lungs can cause shortness of breath and a rapid heart
rate. Lowered oxygen levels may also cause sharp chest pain and damage to lung
tissue. Pulmonary embolism is likely to recur without treatment. Complications of pulmonary embolism Complications of pulmonary embolism may include: Aggressive steps will be considered when treating a large,
life-threatening pulmonary embolism. Death caused by pulmonary embolism usually
occurs within 30 minutes of the onset of symptoms.1 Chronic or recurring pulmonary
embolism Blood clots that cause pulmonary embolism may dissolve on their
own. However, after having had pulmonary embolism, you have an increased risk
of a repeat episode if you do not receive treatment. If pulmonary embolism is
diagnosed promptly, treatment with anticoagulant medications (usually heparin
and warfarin) may prevent new blood clots from forming. The risk of having another pulmonary embolism caused by something
other than blood clots varies. Substances that are reabsorbed into the body,
such as air, fat, or amniotic fluid, usually do not increase the risk of having
another episode. Cancer increases the risk of blood clots. Having multiple episodes of pulmonary embolism can severely reduce
blood flow through the lungs and heart. Over time, this increases blood
pressure in the lungs (pulmonary hypertension), eventually leading to
right-sided
heart failure and possibly
death.
Having a blood clot in the
deep vein of your leg and having a previous
pulmonary embolism are the two greatest risk factors
for pulmonary embolism. For more information on risk factors for blood clots in the legs,
see the topic Deep Vein Thrombosis. Risk factors for developing clots include having slowed blood flow,
abnormal clotting, and a blood vessel injury. Slowed blood flowWhen blood does not circulate normally, clots are more likely to
develop. Reduced circulation may result from: - Long-term bed rest, such as if you are
confined to bed after an operation, injury, or serious illness.
- Traveling and sitting for a long time, especially when traveling
long distances by airplane.5
- Leg
paralysis. Paralysis can reduce circulation because the legs cannot be moved
without help.
Abnormal clottingSome people have blood that clots too easily or too quickly.
People with this problem are more likely to form larger clots that can break
loose and travel to the lungs. Conditions that may cause increased clotting
include: - Inherited factors. Some people have an
inherited tendency to develop blood clots that can lead to pulmonary
embolism.
- Cancer.
- Heart
failure.
- Serious burns.
- Severe
infections.
- Use of birth control pills or other medications that
contain estrogen or estrogenlike hormones.6
- Smoking.
Injury to the blood vessel wallBlood is more likely to clot in veins and arteries shortly after
they are injured. Injury to a vein can be caused by: - Major surgery involving the legs, abdomen, or
pelvis.
- A tube (catheter) placed in a large vein of the body
(central venous catheter).
Other risk factors include: - Pregnancy. A woman's risk of developing
blood clots increases both during pregnancy and shortly after
delivery.
- Age. As people get older (especially older than age 70),
they are more likely to develop blood clots.
- Weight. Being
overweight increases the risk for developing clots.
- Not taking
anticoagulant medication as prescribed.
Call
911 or other emergency
services immediately if you think you have symptoms of
pulmonary embolism. Symptoms include: - Sudden shortness of breath.
- Sharp
chest pain that sometimes becomes worse with deep breathing or
coughing.
- Rapid pulse or
palpitations.
- Sweating.
- Anxiety.
- A cough
that may produce a bloody mucus or blood.
- Fainting.
Call your doctor right away if you have symptoms of a blood clot in
the leg. These symptoms may include: - Swelling in a leg that may make it noticeably
larger than the other leg. Swelling may also appear as a swollen ridge along a
blood vessel that you can feel.
- Skin that is red and warm to the
touch.
- Pain or tenderness in the calf or thigh. The pain may occur
only when standing or walking.
Blood clots in the deep veins of the leg are the most common cause
of pulmonary embolism. For more information on these types of blood clots, see
the topic Deep Vein Thrombosis. Watchful WaitingIf you think you may have pulmonary embolism, call your doctor or
go to the emergency room at the nearest hospital. Watchful waiting is not
appropriate for pulmonary embolism. Who To SeeHealth professionals who can diagnose pulmonary embolism
include: To prepare for your appointment, see the topic
Making the Most of Your Appointment.
Diagnosing
pulmonary embolism is difficult because of the large
number of
other
medical conditions that can cause similar symptoms, such as a
heart attack or an
anxiety attack. Diagnosis depends upon an accurate and thorough
medical history and ruling out other conditions. Your
doctor will need to know about your symptoms and
risk
factors for pulmonary embolism, such as having a prior or family history
of blood clots or having recent surgery. This information, combined with a
careful
physical exam, will guide which initial tests are best
suited to diagnose a
deep vein thrombosis or pulmonary embolism. Tests that are often done if you have shortness of breath or chest
pain include: - A
chest X-ray. Results may rule out an enlarged heart or
injured lung, which may lead to further testing.
- Electrocardiogram (EKG, ECG). The electrical activity
of the heart is recorded with this test. EKG results will help rule out a
possible heart attack.
- Arterial blood gas
analysis. A sudden drop in the blood oxygen level may suggest a
pulmonary embolism.
Results from these initial tests may rule out other conditions,
such as a heart attack or pneumonia. Further testing may include:2 - D-dimer. A d-dimer test is a blood test that
measures a substance released as a blood clot breaks up. D-dimer levels are
usually high in people with pulmonary embolism.
- Spiral (helical) computed tomography. This test is
used commonly in most hospitals to check for pulmonary embolism.
- Ventilation-perfusion scanning. This test scans for
abnormal blood flow through the lungs after a radioactive tracer has been
injected and you breathe a radioactive gas.
- Pulmonary
angiogram. A pulmonary angiogram is the most accurate way to diagnose
pulmonary embolism. This test is not available at some smaller hospitals and is
more invasive than other testing.
- Echocardiogram
(echo). This test detects abnormalities in the size or function of the
heart's right ventricle, which may be an indicator of pulmonary
embolism.
- Doppler ultrasound. A Doppler ultrasound test uses
reflected sound waves to determine whether a blood clot is present in the large
veins of the legs.
- Magnetic resonance
imaging (MRI). This test may be used to view clots in the deep veins and
lungs.
Treatment of
pulmonary embolism focuses on preventing future
pulmonary embolism by using
anticoagulant medications. Anticoagulants prevent
existing blood clots from growing larger and help prevent new ones from
developing. If symptoms are severe and life-threatening, immediate and
sometimes aggressive treatment is needed. Aggressive treatment may include
thrombolytic medications, which can dissolve a blood
clot quickly but also increase the risk of severe bleeding. Another option for
life-threatening, large pulmonary embolism is surgical removal of the clot,
called an embolectomy. This surgery is only available at a few large
hospitals. Some people may also benefit from having a
vena cava filter inserted into the large central vein
of the body. This filter can help prevent blood clots from reaching the lungs.
It is used when anticoagulants are not an option, clots form despite
anticoagulant use, or there is an increased risk of death or a severely
restricted lifestyle if another pulmonary embolism occurs.
Daily use of
anticoagulant medicines may help prevent recurring
pulmonary embolism by stopping new blood clots from
forming and stopping existing clots from growing. Recent studies show that the risk of forming another blood clot is
highest during the 4 to 6 weeks after an initial episode of pulmonary embolism.
This risk decreases over time. However, the risk remains significant for months
and sometimes years depending upon what caused the pulmonary embolism. People
with recurrent blood clots and/or pulmonary embolism may have to take
anticoagulants daily for the rest of their lives.7
Anticoagulant medications also are often used for people who are having surgery
on the legs, abdomen, or pelvis. Other preventive methods may also be used, such as: - Getting you moving shortly after
surgery.
- Wearing
compression stockings to help prevent leg deep vein
thrombosis if you are at increased risk for this condition.
- Taking
a baby aspirin before long airplane or car trips.
Aspirin may reduce the risk of forming blood clots.8 Aspirin, however, is not adequate for treating pulmonary
embolism.
Home treatment is not recommended for initial treatment for
pulmonary embolism. However, it is important for
preventing additional clots from developing and causing a
deep vein thrombosis, which can lead to recurring
pulmonary embolism. Measures that decrease your risk of developing a deep vein
thrombosis include the following: - Exercise. Keep blood moving in your legs by
pointing your toes up toward your head so that your calves are stretched, then
relaxing. Repeat. This exercise is especially important when you are sitting
for long periods of time, for example, on long driving trips or airplane
flights.
- Get up out of bed as soon as possible after an illness or
surgery. It is very important to get moving as soon as you are able. If you
cannot get out of bed, do the leg exercises described above every hour to keep
the blood moving through your legs.
- Quit smoking. This is
especially important if you are using any medications that contain estrogen,
such as birth control pills.
- Wear
compression stockings to help prevent leg deep vein
thrombosis if you are at increased risk for this condition.
For more information on how to prevent clots from developing, see
the topic
Deep
Vein Thrombosis.
Medications can help prevent repeated episodes of
pulmonary embolism by preventing new blood clots from
forming or preventing existing clots from getting larger. Medication Choices Anticoagulants are prescribed when pulmonary embolism
is diagnosed or strongly suspected. Normally, when an injury that causes
bleeding occurs, the body sends out signals that cause the blood to clot at the
wound. The clot naturally breaks down as the wound heals. A person who is prone
to abnormal clotting has an imbalance between clot formation and clot
breakdown. Anticoagulants prevent the production of certain proteins that are
necessary for blood to clot. Although anticoagulants can prevent new clots from
forming and prevent existing clots from getting larger, they do not break up or
dissolve existing blood clots. Heparin and warfarin are the two main types of anticoagulants
used to treat pulmonary embolism. Heparin Heparin is an anticoagulant given by injection. It immediately
affects the clotting system in your body. Oral anticoagulant medication
(warfarin) takes longer to start working. - Initial treatment with a
low-molecular-weight heparin (LMWH) usually is preferred because it can be
given as an injection once or twice per day, and it may be given at home,
allowing you to leave the hospital earlier.9 Blood
tests are not needed to monitor LMWH's clotting effect.
-
Unfractionated heparin is another form that can be used. It is given in the
hospital continuously through your vein (intravenously, or IV). Frequent blood
tests (usually every 6 hours) are required to monitor the clotting effects of
this medication.
Early studies show that LMWH may be equally as effective as
unfractionated heparin in most people with pulmonary embolism.10, 11 However, it is still unclear
whether LMWH is a good choice in treating a large pulmonary embolism. Some
doctors may still prefer to use unfractionated heparin in these severe
cases. Both forms of heparin can cause severe bleeding in some people.
The risk that either type will cause bleeding appears to be about the
same.2 However, if bleeding occurs, unfractionated
heparin can be stopped quickly, whereas LMWH has to wear off. Warfarin (such as Coumadin) Warfarin is an anticoagulant that is taken in pill form. It is
usually started while a person is still being treated with heparin because it
takes several days for warfarin to build up to a level that's effective. Once
the warfarin is at a proper level, heparin is discontinued and treatment with
warfarin continues. Studies show that treatment using heparin and warfarin
reduces the risk of death from pulmonary embolism.11
Typically, full-dose warfarin is given for at least 3 to 6
months or longer after pulmonary embolism to reduce the risk of having another
blood clot. Treatment with anticoagulants may continue throughout your life if
the risk of having another pulmonary embolism remains high. Talk with your
doctor about whether continuing low-dose warfarin after your initial treatment
might be right for you. For those people with ongoing risk factors, such as cancer,
anticoagulant treatment continues as long as those risk factors are present.
Some people with inherited blood-clotting disorders or a history of recurrent
deep vein thrombosis or pulmonary embolism may take oral anticoagulants for the
rest of their lives. Because warfarin can increase the risk of birth defects,
pregnant women with pulmonary embolism are limited to
taking heparin. A few days after the baby is born, a woman can switch from
heparin to warfarin. Thrombolytics Thrombolytic medications are not commonly used to
treat pulmonary embolism. Although they can quickly dissolve a blood clot,
thrombolytics also greatly increase the risk of serious bleeding. They are
occasionally used to treat a life-threatening pulmonary embolism. What To Think AboutOnce pulmonary embolism is diagnosed, a doctor considers: - Whether anticoagulant medications are
appropriate.
- How long anticoagulants should be used.
If you have had a recent major stroke, surgery, or active
internal bleeding, you usually cannot take anticoagulant or thrombolytic
medications. A
vena cava filter may help to reduce the risk of
another pulmonary embolism in this case. It's important that you keep the following safety tips in mind
when taking warfarin. Safety tips for anticoagulants- Take the medication at the same time each
day.
- Check with your doctor before using nonprescription drugs,
especially ones that contain aspirin.
- Tell any new health
professionals that you are taking medication that affects how your blood
clots.
- Be alert for signs of bleeding, and call the doctor
immediately if any of the following symptoms occur:
- Blood in urine or red or black tarry
stools
- Nosebleeds that are hard to stop
- Spitting up
blood
- New, excessive, or prolonged vaginal
bleeding
- Frequent, severe bruising or tiny red or purple spots on
the skin
- Talk to your doctor about medications you are
taking to find out how often you should have blood tests.
If you are taking the anticoagulant ticlopidine, get frequent
blood tests to check your white blood cell count during the first 3 months of
treatment. If you take warfarin (such as
Coumadin): - Get regular blood tests to ensure that you
are taking the right amount of medication.
- Eat a balanced diet.
Don't suddenly change your intake of vitamin K–rich foods, such as broccoli,
brussels sprouts, cabbage, asparagus, lettuce, spinach, and some vegetable
juices. It is most important to maintain a consistent level of vitamin K foods
in your diet. Vitamin K can interfere with the action of warfarin, making it
more likely that your blood will clot.
- Avoid excessive use of
alcohol. If you drink, do so only in moderation. Chronic drinking may cause
liver damage and increase the effect of warfarin.
- Don't use
tobacco of any kind.
- Avoid activities that have a high risk for
injury, such as skiing, football, or other contact sports. If you are taking
warfarin, an injury could result in excessive bleeding.
- Wear a seat
belt anytime you are traveling in a car.
Preventing minor bleeding while taking anticoagulantsYou may find it helpful to use the following items to lower
your risk of bleeding: - An electric razor
- A
soft-bristled toothbrush and waxed floss
- Protective clothing, such
as gloves and shoes
- Nonslip mats in the tub and shower
Surgical removal of a clot is called an embolectomy. This type of
treatment for
pulmonary embolism is rarely used. It is considered
when the clot in the main pulmonary artery is extremely large and
life-threatening and is causing severe symptoms.7 An
embolectomy also may be an option for a person whose condition is stable but
who shows signs of significant reduced blood flow in the pulmonary artery.
What to Think About Surgery increases the risk of forming new blood clots that can
cause another pulmonary embolism.
Some people cannot take anticoagulant medications, or they continue
to develop blood clots despite taking the medications. If surgery or
medications are not options, other methods of preventing pulmonary embolism may
be considered, such as a vena cava filter. Other Treatment ChoicesA
vena cava filter may be inserted in the large central
vein that passes through the abdomen and returns blood from the body to the
heart (vena cava). This filter can prevent blood clots in the leg or pelvic
veins from traveling to the lungs and heart. These filters may be permanent or
removable. Studies have shown that vena cava filters help prevent pulmonary
embolism. However, they may be most effective when combined with anticoagulant
therapy. What To Think AboutVena cava filters are not recommended as an initial treatment for
pulmonary embolism. However, they may be considered if you: - Continue to have pulmonary embolism despite
taking anticoagulant medication.
- Cannot take anticoagulants because
of bleeding risk.
- Have an increased risk of death or a severely
restricted lifestyle should another pulmonary embolism occur.
Vena cava filters may benefit people who have had a pulmonary
embolism surgically removed (embolectomy) if another pulmonary embolism would
likely be fatal or severely limit a person's lifestyle. Vena cava filters can cause serious health problems if they
become blocked with one or more blood clots. Vena cava filters have not been shown so far to lower the death
rate in people with pulmonary embolism.
Organizations| American Heart Association (AHA) | | 7272 Greenville Avenue | | Dallas, TX 75231 | | Phone: | 1-800-AHA-USA1 (1-800-242-8721) | | Web Address: | http://www.americanheart.org | | | Call the American Heart Association (AHA) to find your nearest
local or state AHA group. The AHA can provide brochures and information on
support groups and community programs, including Mended Hearts, a nationwide
organization whose members visit heart patients and provide information and
support. |
| | American Venous Forum | | 203 Washington Street | | Suite PMB no. 311 | | Salem, MA 09170 | | Phone: | (978) 744-5005 | | Web Address: | http://www.dvt-info.com/ | | | The mission of the American Venous Forum is to improve the care of
patients with vein and lymph disorders by providing a forum for education and
the exchange of information about basic and clinical research in the venous and
lymphatic systems. The Web site offers an online book entitled The Layman's Handbook of Venous Disorders that explains basic
terms and treatment options and offers answers to frequently asked
questions. |
| | National Heart, Lung, and Blood Institute
(NHLBI) | | P.O. Box 30105 | | Bethesda, MD 20824-0105 | | Phone: | (301) 592-8573 | | Fax: | (240) 629-3246 | | TDD: | (240) 629-3255 | | E-mail: | nhlbiinfo@nhlbi.nih.gov | | Web Address: | http://www.nhlbi.nih.gov/ | | | The National Heart, Lung, and Blood Institute (NHLBI) information
center offers information and publications about preventing and treating heart,
lung, and blood diseases. |
|
CitationsAmerican College of Obstetricians and Gynecologists
(2000). Prevention of deep vein thrombosis and pulmonary embolism. ACOG
Practice Bulletin No. 21. Obstetrics and Gynecology,
96(4): 1–10. Tapson V (2004). Pulmonary embolism. In L Goldman, D
Ausiello, eds., Cecil Textbook of Medicine, 22nd ed.,
vol. 1, pp. 560–568. Philadelphia: Saunders. Kearon C, Hirsh K (2003). Pulmonary embolism section
of Venous thromboembolism. In DC Dale, DD Federman, eds., Scientific American Medicine, vol. 1 part 1, chap. 18. New
York: WebMD. Rossi SE, et al. (2000). Nonthrombotic pulmonary
emboli. American Journal of Roentgenology, 174(6):
1499–1508. Lapostolle F, et al. (2001). Severe pulmonary embolism associated with air travel. New England Journal of Medicine, 345(11): 779–783. Grady D, et al. (2000). Postmenopausal hormone therapy increases risk for venous thromboembolic disease: The heart and estrogen/progestin replacement study. Annals of Internal Medicine, 132(9): 689–696. Task Force on Pulmonary Embolism, European Society of
Cardiology (2000). Task force report: Guidelines on diagnosis and management of
acute pulmonary embolism. European Heart Journal,
21(16): 1301–1336. Pulmonary Embolism Prevention (PEP) Trial Collaborative Group (2002). Prevention of pulmonary embolism and deep vein thrombosis with low-dose aspirin: Pulmonary embolism prevention (PEP) trial. Lancet, 355(9212): 1295–1302. Hyers TM, et al. (2001). Antithrombotic therapy for
venous thromboembolic disease. Sixth ACCP Consensus Conference on
Antithrombotic Therapy. Chest, 119(1 Suppl):
176S–193S. Hull RD, et al. (2000). Low-molecular-weight heparin
versus heparin in the treatment of patients with pulmonary embolism.
Archives of Internal Medicine, 160(2):
229–236. Fitzmaurice D, et al. (2004). Thromboembolism.
Clinical Evidence (11): 284–299.
Other Works ConsultedAgency for Healthcare Research and Quality (2003).
Diagnosis and Treatment of Deep Venous Thrombosis and Pulmonary
Embolism. Evidence Report/Technology Assessment No. 68. (AHRQ
Publication No.03–E012). Rockville, MD: Agency for Healthcare Research and
Quality. Kearon CK, et al. (2003). Comparison of low-intensity
warfarin therapy with conventional-intensity warfarin therapy for long-term
prevention of recurrent venous thromboembolism. New England
Journal of Medicine, 349(7): 631–639. Kucher N, Tapson VF (2004). Pulmonary embolism. In V
Fuster et al., eds., Hurst's The Heart, 11th ed., pp.
1593–1616. New York: McGraw-Hill. Tapson VF (2002). Venous thromboembolism. In EJ Topol, ed., Textbook of Cardiovascular Medicine, 2nd ed., pp. 667–684. Philadelphia: Lippincott Williams and Wilkins.
| Author | Ellie Rodgers | | Editor | Geri Metzger | | Associate Editor | Terrina Vail | | Primary Medical Reviewer | Caroline S. Rhoads, MD - Internal Medicine | | Specialist Medical Reviewer | Jeffrey S. Ginsberg, MD - Hematology | | Last Updated | February 25, 2005 |
|